Bank of America’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bank of America’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,000	Closed	-$3.1M	–	8538
2025 Q1	$3.1M	Buy	+25,000	New	+$3.26M	﹤0.01%	4278
2020 Q2	–	Sell	-33,700	Closed	-$3.36M	–	6963
2020 Q1	$3.36M	Buy	33,700 +12,500	+59%	+$1.62M	﹤0.01%	3051
2019 Q4	$3.17M	Buy	+21,200	New	+$2.88M	﹤0.01%	3643
2018 Q1	–	Sell	-10,000	Closed	-$1.35M	–	7210
2017 Q4	$1.35M	Hold	10,000	–	–	﹤0.01%	4286
2017 Q3	$1.46M	Buy	+10,000	New	+$1.51M	﹤0.01%	4242
2017 Q1	–	Sell	-15,000	Closed	-$1.64M	–	7106
2016 Q4	$1.64M	Sell	15,000 -5,000	-25%	-$557K	﹤0.01%	3941
2016 Q3	$2.43M	Buy	20,000 +15,000	+300%	+$2.02M	﹤0.01%	3489
2016 Q2	$707K	Buy	+5,000	New	+$737K	﹤0.01%	4431
2015 Q1	–	Sell	-1,800	Closed	-$295K	–	7308
2014 Q4	$295K	Sell	1,800 -4,100	-69%	-$681K	﹤0.01%	5049
2014 Q3	$947K	Buy	5,900 +3,200	+119%	+$492K	﹤0.01%	4032
2014 Q2	$397K	Sell	2,700 -200	-7%	-$27.7K	﹤0.01%	4853
2014 Q1	$402K	Buy	+2,900	New	+$437K	﹤0.01%	4809

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Bank of America's JAZZ Position: Q1 2026 in Review

Bank of America increased its Jazz Pharmaceuticals (JAZZ) stake by 11% in Q1 2026, buying an estimated $17.4M and bringing the position to 1,014,800 shares worth $192M. The position accounts for 0.01% of the portfolio, ranked #757.

Bank of America first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. 572 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Bank of America held 1,014,800 shares of Jazz Pharmaceuticals worth $192M as of Q1 2026.
Bank of America bought 99,656 Jazz Pharmaceuticals shares in Q1 2026, an estimated $17.4M.
Jazz Pharmaceuticals made up 0.01% of Bank of America's portfolio in Q1 2026, its #757 holding.
Bank of America first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
572 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.